A Pharma-Backed Effort to Curb Oversight on Psych Meds Fails in California Legislature
Following pressure from foster youth advocates, legislation that would have scaled back patient protections for Californians prescribed the most powerful psychiatric drugs will no longer be heard by the state Legislature this year.
Amid Pandemic, A Pharma-Backed Effort to Ease Oversight on Psych Meds
As the California Assembly struggles to begin creating new laws on Monday amid the ravages of the coronavirus pandemic, lawmakers are being urged to select only the most vital-to-the-times bills. To contain infections that have topped 43,000 in the state, there will be masks and gloves, and people seated far from each other in cavernous hearing rooms.
Despite National Concern Over Psych Drugs For Foster Youth, New York City Says It Lacks Key Data
In the Bronx, Pedro Maldonado’s story of diagnosis and prescription for Concerta and Seroquel — typically prescribed for ADHD and mood disorders like schizophrenia — started when he was in foster care at age 6.
Potential ‘Landmark’ Settlement Reached on Use of Psychotropic Drugs in Foster Care
Missouri has reached a settlement in a class-action lawsuit that litigants hope will set some precedent on a once-hot-button subject in child welfare: the use of psychotropic medication to treat youth in foster care.
Judge OKs Class Action on Overuse of Psych Meds on Missouri Foster Youths
A federal judge has granted class-action status to a lawsuit regarding alleged overuse of psychotropic medication by Missouri’s child welfare agency. United States District Judge Nanette Laughrey announced in a decision dated July 19 that the plaintiffs in the case will include “all children in … foster care custody who presently are, or will be, prescribed or administered one or more psychotropic medications while in state care.”
Lawsuit Over Psychotropics and Foster Youth Will Move Forward
U.S. District Judge Nanette Laughrey ruled this week that a class-action lawsuit over Missouri’s use of psychotropic medications for youth in foster care can continue. The decision moves forward a case that could potentially set some precedent on an issue that heated up in the earlier half of the decade and has taken a back burner lately: the mental health rights and treatment of vulnerable children.
In Response to Karen de Sá’s Article in The San Jose Mercury News
The trauma that children and youth in foster care experience is a serious issue which deserves not only our attention, but our concerted action to eliminate it. A recent article in the San Jose Mercury News (SJMN) suggests that Hillsides and a consulting psychiatrist contributed to this trauma after psychotropic medication was prescribed to a former resident who was discharged from our care eight years ago.
Child Welfare Ideas from the Experts, #12: Regulating Psych Meds for Foster Youth
The Imprint is highlighting each of the policy recommendations made this summer by the participants of the Foster Youth Internship Program (FYI), a group of 12 former foster youths who completed congressional internships.
A Potential Template Emerges for Federal Action on Foster Care Drugging
Few people outside of California probably noticed the news yesterday that the state legislature is on its way to passing new controls on the prescription of psychotropic medications to youths in foster care.